Lexaria Bioscience Corp LEXX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:06 PM EDT
5.05quote price arrow down-0.04 (-0.79%)
Volume
15,129
52 week range
3.98 - 15.64

...

Loading . . .
  • Open5.10
  • Day High5.21
  • Day Low4.96
  • Prev Close5.09
  • 52 Week High15.64
  • 52 Week High Date07/20/20
  • 52 Week Low3.98
  • 52 Week Low Date01/12/21

Key Stats

  • Market Cap25.76M
  • Shares Out5.10M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.70
  • YTD % Change-32.34

KEY STATS

  • Open5.10
  • Day High5.21
  • Day Low4.96
  • Prev Close5.09
  • 52 Week High15.64
  • 52 Week High Date07/20/20
  • 52 Week Low3.98
  • 52 Week Low Date01/12/21
  • Market Cap25.76M
  • Shares Out5.10M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.70
  • YTD % Change-32.34

RATIOS/PROFITABILITY

  • EPS (TTM)-1.09
  • P/E (TTM)-4.64
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-3.771M
  • ROE (MRQ)-169.21%
  • Revenue (MRQ)620,000.00
  • Gross Margin (MRQ)74.76%
  • Net Margin (MRQ)-626.57%
  • Debt To Equity (MRQ)1.64%

EVENTS

  • Earnings Date07/05/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Lexaria Bioscience Corp

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Lexaria Bioscience Corp is a healthcare company. The Company is primarily engaged in developing drug delivery technology, DehydraTECH, which improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules, thereby lowering overall dosing. The Company's technology can be applied to many different ingestible product formats, including foods, beverages...
Christopher Bunka
Chairman
John Docherty
President
Allan Spissinger
Chief Financial Officer
Address
100 - 740 MCCURDY ROAD
Kelowna, BC
V1X 2P7
Canada